LB Pharmaceuticals Inc Common Stock (LBRX) is a publicly traded the market company. As of May 21, 2026, LBRX trades at $27.83 with a market cap of $795.49M and a P/E ratio of -8.88. LBRX moved +2.86% today. Year to date, LBRX is +36.33%; over the trailing twelve months it is flat. Its 52-week range spans $13.36 to $33.47. Analyst consensus is strong buy with an average price target of $46.00. Rallies surfaces LBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded LBRX stock?
Rallies tracks politician and congressional stock disclosures for LBRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for LBRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in LBRX?
Yes. Rallies tracks politician and congressional stock disclosures for LBRX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is LBRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LBRX. It does not provide personalized investment advice.
